EX-23.1 4 f10k2022ex23-1_cadrenal.htm CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-268372) of Cadrenal Therapeutics, Inc. of our report dated March 29, 2023, relating to the consolidated financial statements, which appears in this Form 10-K.

 

/s/ WithumSmith+Brown, P.C.  
East Brunswick, New Jersey  
March 29, 2023